PAM
LJPC

Premier Asset Management’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Premier Asset Management’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-51,305
Closed -$217K – 213
2021
Q1 		$217K Sell
51,305
-25,629
-33% -$141K 0.04% 179
2020
Q4 		$299K Buy
+76,934
New +$329K 0.06% 142
2020
Q2 		– Sell
-29,865
Closed -$125K – 149
2020
Q1 		$125K Buy
+29,865
New +$189K 0.05% 102

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Premier Asset Management's LJPC Position: Q2 2021 in Review

Premier Asset Management sold out of La Jolla Pharmaceutical Company (LJPC) in Q2 2021, closing a stake of 51,305 shares — an estimated $217K sold.

Premier Asset Management first reported a position in LJPC in Q1 2020 and held it in 3 quarters. The position peaked at $299K in Q4 2020. 62 funds tracked by Wall St. Rank hold LJPC as of Q2 2021.

  • Premier Asset Management reported no remaining La Jolla Pharmaceutical Company position as of Q2 2021 after selling out during the quarter.
  • Premier Asset Management sold 51,305 La Jolla Pharmaceutical Company shares in Q2 2021, an estimated $217K.
  • Premier Asset Management first reported a position in La Jolla Pharmaceutical Company in Q1 2020 and held it in 3 quarters.
  • Premier Asset Management's La Jolla Pharmaceutical Company position peaked at $299K in Q4 2020.
  • 62 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q2 2021.

Based on Premier Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.